Stuart M. Rennie
Stuart M. Rennie is member of the 2018 Guideline Development Group (GDG) of the WHO. The GDG's task is to develop updated recommendations on safe male circumcision for HIV prevention and related service delivery for adolescent boys and men in generalized HIV epidemics.[1]
Biography
The WHO published the following biography of Stuart M. Rennie:
RENNIE, Stuart M
- University of North Carolina at Chapel Hill, United States
- MA (Anthropology), PhD (Philosophy)
- Chapel Hill, North Carolina, USA
Stuart Rennie is Faculty Associate at the University of North Carolina (UNC) Center for Bioethics and Associate Professor in the UNC Department of Social Medicine, Chapel Hill, USA.
His current interests focus on research ethics, public health ethics and medical ethics in developing countries, primarily in sub-Saharan Africa. He is co-Principal Investigator of two NIH/Fogarty International Center bioethics capacity building projects in Central Francophone Africa and South Africa. At UNC, he teaches bioethics to medical students in the School of Medicine. He is also co-Principal Investigator of a research study on the ethical and social implications of HIV cure research, with study sites in the USA, China and South Africa. He is currently also co-investigator in a NIH study on responsible conduct of HIV research among adolescents in Kenya. He has published on many bioethics themes, including informed consent, HIV testing policies, medical rationing, implementation ethics, research involving children, health surveillance, health inequality and social justice. He was co-lead author of the HIV Prevention Trials Network (HPTN) Ethical Guidance for Research (2009). He has conducted qualitative research on community attitudes towards male circumcision as means of HIV prevention in Malawi, and has published about the ethical dimensions of this public health intervention.[2]
PubMed indicates that Rennie is a named author of seven papers. Only one touches on non-therapeutic male circumcision.[3] Rennie's position on non-therapeutic male circumcision is not clear. Based on this article, if Rennie were shown that male circumcision to prevent HIV infection is not cost-effective, he might be persuaded to take a position against non-therapeutic male circumcision.
References
- ↑
(May 2018). WHO to develop new guidelines on male circumcision
. Retrieved 26 March 2020. - ↑
Biographies of Guideline Development Group (GDG) members for WHO guidance 
, WHO. (September 2018). Retrieved 26 March 2020.
- ↑
Rutstein SE, Price JT, Rosenberg NE, Rennie SM, Biddle AK, Miller WC. Hidden Costs: the ethics of cost-effectiveness analyses for health interventions in resource-limited settings. Glob Public Health. October 2017; 12(10): 1269-81. PMID. PMC. DOI. Retrieved 3 April 2020.
.svg){kind=icon}
